Collegium to Present at Jefferies and William Blair Conferences
Jefferies Healthcare Conference ,New York ,June 7 th at10 a.m. ET - William Blair Annual
Growth Stock Conference ,Chicago ,June 16 th at10 a.m. CT
About
Collegium is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its proprietary DETERx® technology platform for the treatment of chronic pain and other diseases. The DETERx technology platform is designed to provide extended-release delivery, unique abuse-deterrent properties, and flexible dose administration options.
About Xtampza ER
Xtampza™ ER is Collegium’s first product utilizing the DETERx technology platform. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone approved by the
For Important Safety Information Visit, http://www.xtampzaer.com/
Contact:Douglas Carlson Vice President, Corporate Development dcarlson@collegiumpharma.com